<i>In vitro</i> inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutations - Concepedia

Concepedia

Publication | Closed Access

<i>In vitro</i> inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutations

125

Citations

22

References

2012

Year

Xueyan Wang, Zhenman Wei, Guoyi Wu, Jianghua Wang, Ying‐Jun Zhang, Jing Li, Henghui Zhang, Xingwang Xie, Xian Wang, Zhao-He Wang,

Antiviral Therapy

Abstract

GLS4 is a new and unique potential anti-HBV agent that possesses a different mechanism of action than existing therapeutic drugs.

References

	Year	Citations

Page 1